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ABSTRACT
INTRODUCTION Parathyroidectomy is the definitive treatment for primary hyperparathyroidism but the intraoperative identification
of adenomas is challenging. The aim of this study was to evaluate the utility of a radionuclide probe (RNP) in addition to intraopera-
tive parathyroid hormone ( IOPTH) measurement as an intraoperative diagnostic adjunct in patients undergoing parathyroidectomy
for primary hyperparathyroidism.
METHODS This was a retrospective cohort study of patients treated between 2004 and 2015 in a university affiliated teaching hos-
pital. Patients were grouped into those with RNP use (RNP+) and those without (RNP-). The primary outcome measure was rate of
operative failure, which included false positives. The diagnostic sensitivity and positive predictive value of both RNP and IOPTH
were also evaluated.
RESULTS A total of 298 patients were included in the study, 127 (42.6%) being in the RNP+ group and 171 (57.4%) in the
RNP- group. The false positive rate for the RNP+ patients was 1.6% compared with 9.4% for RNP- patients (p=0.006, hazard ratio
[HR]: 6.45). The rates of operative failure were 6.3% and 11.7% respectively (p=0.159, HR: 1.97). RNP use had a sensitivity of
92.0% and a positive predictive value of 98.3% compared with 78.6% and 95.2% respectively for IOPTH monitoring.
CONCLUSIONS RNP use is associated with fewer false positives and reduced operative failure than IOPTH measurement. It also
has a higher sensitivity and positive predictive value. RNP use is recommended in centres that have the required facilities.
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Primary hyperparathyroidism (pHPT) is a common endo-
crine disorder with a prevalence of 0.21–2.2%.1 It is caused
by autonomous hypersecretion of parathyroid hormone in
one or more parathyroid glands resulting in hypercalcae-
mia.2 If left untreated, it may lead to clinical symptoms such
as accelerated bone loss, renal stones, fatigue, depression
and cardiovascular disease.3
Parathyroidectomy is the only definitive treatment for
pHPT; its success is largely aided by positive preoperative
imaging for localisation and excellent intraoperative tests to
confirm adequate resection.4 Although sestamibi scintigra-
phy or ultrasonography of the neck can been employed pre-
operatively to assist in surgical resection, their sensitivities
in detecting parathyroid adenomas are limited. In one study,
a combination of sestamibi imaging and ultrasonography of
the neck only achieved a sensitivity of 88%.5 Consequently,
it is clear that other intraoperative tests are necessary as
adjuncts to surgery to optimise patient outcome.
The introduction of intraoperative parathyroid hormone
(IOPTH) monitoring and a well defined criterion for
successful exploration proposed by Irvin et al revolutionised
parathyroid surgery in the 1990s,6 prompting many surgeons
to adopt focused parathyroidectomy.7,8 IOPTH has a sensitiv-
ity of 80–95% but is still associated with false positives.9,10
Furthermore, Siperstein et al reported a potential 16% fail-
ure rate in a large cohort of patients undergoing focused
parathyroidectomy despite concordant sestamibi imaging
and IOPTH measurement.11 Others report fluctuation
including increases in IOPTH levels following parathyroi-
dectomy.12 This discrepancy may be due to intraoperative
manipulation of the parathyroid glands and may result in
diagnostic uncertainty if IOPTH testing was the sole intrao-
perative diagnostic adjunct.
The radionuclide probe (RNP), on the other hand, is safe
and associated with a 94% success rate in patients under-
going parathyroidectomy.13 In patients with pHPT, RNPs
may be used as a valuable adjunct to surgery to reduce the
risk of operative failure, which (although rare) remains a
major problem as repeat surgery is often more difficult, with
greater risk of complications. The aim of this study was to
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evaluate the benefit of RNP use in addition to IOPTH meas-
urement as an intraoperative diagnostic adjunct in patients
undergoing parathyroidectomy for pHPT.
Methods
This was a retrospective cohort study utilising a prospec-
tively maintained database in Cork University Hospital, a
large university affiliated tertiary referral centre in Ireland.
Ethical approval for the study was obtained from the clinical
research ethics committee at University College Cork. All
adult patients undergoing parathyroidectomy for pHPT
between 2004 and 2015 were included. Patients on lithium
therapy, those with less than 30 days of follow-up and those
with missing data were excluded as these confound the
assessment of operative failure.
In our practice, all patients scheduled for parathyroidec-
tomy undergo sestamibi scintigraphy for preoperative local-
isation and IOPTH measurement as an intraoperative
diagnostic adjunct. If imaging is undertaken on the day of
surgery, the RNP is employed intraoperatively as an addi-
tional diagnostic adjunct using Norman’s 20% rule.14 Mini-
mally invasive surgery is performed if scintigraphy
localisation is successful and open exploration beginning at
the lower pole of the left thyroid lobe is performed other-
wise. When a grossly enlarged gland suspicious for parathy-
roid adenoma is encountered and resected, and if the
diagnosis is supported by intraoperative adjuncts, the opera-
tion is considered successful and does not proceed to a full
four-gland exploration.
Our hypothesis was that RNP use is associated with fewer
false positives and greater diagnostic sensitivity. In order to
test this, patients were divided into two groups: those with
RNP use (RNP+) and those without (RNP-). The primary out-
come measure was operative failure, which included false
positives. These were defined as intraoperative diagnosis of
parathyroid adenoma without this being the case on histopa-
thology and disease persistence or recurrence during the
follow-up period. Additionally, the sensitivity and positive
predictive value (PPV) of each modality was calculated. Data
were analysed using Student’s t-test, Fisher’s exact test and
the chi-squared test where appropriate with the aid of SPSS®
version 22 (IBM, New York, US) and Prism® version 6 (
GraphPad Software, La Jolla , CA, US ). All p-values were
derived from two-tailed tests and a p-value of <0.05 was con-
sidered statistically significant.
Results
A total of 298 patients were included in the study, 127
(42.6%) being in the RNP+ group and 171 (57.4%) in the
RNP- group. Differences in patient demographics, serum
biochemistry and adenoma characteristics did not achieve
statistical significance with the exception of estimated glo-
merular filtration rate, and initial and final corrected cal-
cium (Table 1). pHPTwas more prevalent in female patients
in both cohorts, outnumbering male patients by four to one.
Most patients were on the older side of middle age and the
average follow-up duration was one year. Adenomas were
most commonly located at the lower pole of the left thyroid
lobe, followed by the lower pole of the right lobe. Seven
cases of single adenomas were identified without docu-
mented locations. Among the single adenomas, 1.0% were
found in ectopic locations and the incidence of multiglandu-
lar disease (MGD) including four-gland hyperplasia was
7.4%.
There were no significant differences between the groups
in terms of IOPTH results. The overall rate of operative fail-
ure was 9.4%: 6.3% in cases with RNP use and 11.7% in
cases without. The hazard ratio was 1.97 in favour of RNP
use but owing to the rarity of this event, this failed to reach
statistical significance (p=0.159). The overall rate of false
positives was 6.0%: 1.6% in cases with RNP use and 9.4% in
cases without. The hazard ratio was 6.45 in favour of RNP
use and this difference was statistically significant despite its
rarity (p=0.006). These outcomes are presented in Table 1.
The sensitivity and PPV for each intraoperative diagnostic
adjunct was also evaluated. The sensitivity of the RNP was
92.0% compared with 78.6% for IOPTH while the PPV was
98.3% and 95.2% respectively.
Discussion
Intraoperative diagnosis of parathyroid adenomas can be
challenging. Our results show that patients in the RNP+
group had a lower rate of false positives than those in the
RNP- group. This translated to a lower rate of operative fail-
ure for RNP+ patients. This is explained by its high sensitivity
and PPV, which allows it to better identify resected diseased
glands than IOPTH measurement. Radionuclide adminis-
tered for sestamibi scintigraphy is taken up by both thyroid
and parathyroid tissue but is washed out of thyroid tissue
relatively rapidly, allowing for the interpretation of the imag-
ing. By the time the patient is brought to theatre, only dis-
eased parathyroid tissue retains more than 20% of
radioactivity compared with background levels, as described
by the Norman group.14
As both scintigraphy and RNP results are dependent on
radionuclide uptake by diseased glands, some may argue
that RNP use shares the weakness of sestamibi imaging in
the identification of MGD (including parathyroid hyperpla-
sia). However, in studies of parathyroid hyperplasia secon-
dary to chronic renal disease, RNP use was shown to retain
its utility and improve the success of surgery.15,16 We believe
RNP should behave similarly for parathyroid hyperplasia in
pHPT. In a study of 845 patients treated with focused para-
thyroidectomy guided by IOPTH monitoring, the authors
concluded that it was the inability of the surgeon to find the
abnormal parathyroid gland (rather than missed MGD) that
led to operative failure.17
We propose that RNP use be paired with IOPTH measure-
ment; IOPTH levels may not drop appropriately in cases of
MGD, which should prompt further exploration in which the
RNP has utility in identifying disease. Our results support
this as there was no significant difference in rates of MGD
between the RNP+ and RNP- groups. A total of 22 patients
had MGD; 6 of these were in the RNP+ cohort. In five of the
six RNP+ cases, ex vivo counts were greater than 20% of
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background. In contrast, IOPTH levels failed to drop appro-
priately for 11 of the 22 patients after resection of their
glands.
RNP use is safe and quick as it involves no intervention
beyond placing the RNP first over the thyroid bed to obtain a
background reading and then again over the resected tissue.
There is a risk of false positives in the case of concomitant
thyroid disease, such as an undiagnosed follicular thyroid
adenoma.18 Nevertheless, our results show that these cases
are rare and are usually apparent on gross examination by
the operating surgeon.
At the other end of the spectrum, there is a risk of false
negatives, most commonly if surgery is delayed too long
after administration of the radionuclide. This risk can be
alleviated by performing surgery within 3.5 hours of sesta-
mibi scintigraphy, as described by the Norman group.14 In
our experience, therefore, the primary downside of this
technique is the difficulty in logistics (organising imaging on
the day of surgery, allowing time for its interpretation by
radiology colleagues and then having the patient ready for
the operation within 3.5 hours of the imaging).
While the two cohorts in this study were evenly matched
for most variables tested, renal function was worse in the
RNP+ group, and these patients also had higher initial and
final corrected calcium levels. Differences in renal function
may influence calcium homeostasis. However, in the
absence of other evidence of kidney disease, a glomerular
filtration rate of >60ml/min/1.73m2 is considered normal
and the means of both groups were well above this. We
argue that although statistically significant, the difference in
renal function would be clinically negligible.
Likewise, the mean initial corrected calcium values for
both cohort groups were well over the upper limit of normal
and the final corrected calcium values were well below this
Table 1 Comparison of variables for cases with and without RNP use
RNP+ (n=127) RNP- (n=171) p-value
Demographics
Male 27 (21.3%) 31 (18.1%) 0.555
Female 100 (78.7%) 140 (81.9%)
Mean age (years) 60.7 (SEM: 1.3) 62.4 (SEM: 1.1) 0.314
Mean eGFR (ml/min/1.73m2 ) 71.7 (SEM: 1.8) 79.0 (SEM: 1.9) 0.008
Mean follow-up duration (months) 12.3 (SEM: 0.8) 12.1 (SEM: 0.8) 0.870
Biochemistry
Mean initial PTH (pg/ml) 150 (SEM: 9.7) 138 (SEM: 9.6) 0.397
Mean initial calcium (mmol/l) 2.84 (SEM: 0.02) 2.78 (SEM: 0.02) 0.013
Mean final calcium (mmol/l) 2.43 (SEM: 0.02) 2.37 (SEM: 0.01) 0.004
Adenoma size
Mean diameter (cm) 1.91 (SEM: 0.07) 1.78 (SEM: 0.07) 0.213
Mean weight (g) 1.17 (SEM: 0.11) 1.07 (SEM: 0.13) 0.564
Adenoma location
Left lobe, upper pole 24 (18.9%) 19 (11.1%) 0.336
Left lobe, lower pole 42 (33.1%) 44 (25.7%)
Right lobe, upper pole 15 (11.8%) 26 (15.2%)
Right lobe, lower pole 35 (27.6%) 43 (25.1%)
Unknown 2 (1.6%) 5 (2.9%)
Ectopic 1 (0.8%) 2 (1.2%)
Multiglandular disease 6 (4.7%) 16 (9.4%) 0.179
Outcome
Intraoperative PTH drop >50% 100 (78.7%) 131 (76.6%) 0.677
No adenoma 2 (1.6%) 16 (9.4%) 0.006 (HR: 6.45)
Operative failure 8 (6.3%) 20 (11.7%) 0.159 (HR: 1.97)
eGFR = estimated glomerular filtration rate ; HR = hazard ratio; PTH = parathyroid hormone; RNP = radionuclide probe; SEM = standard
error of means
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limit. Two-way analysis of variance was performed to evalu-
ate any difference in the drop in serum calcium postopera-
tively between the groups but there was no statistically
significant difference (p=0.970). Furthermore, if these differ-
ences in calcium levels and renal function had any clinical
significance, they should have resulted in an increase in
operative failure for RNP+ patients but in the fact the oppo-
site was the case.
Finally, a potential criticism of our study is our lack of
data on complication rates. The only difference in the man-
agement of each group was the use of the RNP, which has
been demonstrated to be safe. In a series of 1,650 patients
(with half undergoing open exploration and half focused
parathyroidectomy), the overall complication rate was 2%.19
It is reasonable to conclude that parathyroidectomy is rela-
tively safe and given our small numbers, any difference in
complication rates would have no statistical significance.
Conclusions
The RNP is simple and easy to use, reduces the risk of false
positives and overall operative failure, and increases diag-
nostic sensitivity. Despite RNP use in parathyroidectomy
being described over a decade ago, it may be underutilised
because of the success of IOPTH measurement. However,
RNP use has benefit when employed in conjunction with
IOPTH monitoring and the RNP should be used in every
centre with the required facilities for the best patient
outcome.
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Table 2 Diagnosis of adenoma using a radionuclide probe or





Ex/in vivo counts >20% 115 2 Sensitivity: 92.0%
PPV: 98.3%Ex/in vivo counts <20% 10 0
IOPTH drop >50% 220 11 Sensitivity: 78.6%
PPV: 95.2%IOPTH drop <50% 60 7
IOPTH = intraoperative parathyroid hormone; PPV = positive
predictive value
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